Michael Ulz - Morgan Stanley Analyst Performance This page shows the methodology used to calculate Michael Ulz's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsKPTIKaryopharm Therapeutics8/12/2025$3.77$25.00Outperform???%???%RYTMRhythm Pharmaceuticals8/5/2025$88.57$109.00Overweight???%???%ALNYAlnylam Pharmaceuticals8/1/2025$392.24$405.00Equal Weight???%???%IONSIonis Pharmaceuticals7/31/2025$43.37$62.00Overweight???%???%RYTMRhythm Pharmaceuticals7/9/2025$87.51$95.00Overweight???%???%KPTIKaryopharm Therapeutics5/13/2025$6.15$42.00Outperform???%???%SLNSilence Therapeutics5/9/2025$3.73$25.00Overweight???%???%VKTXViking Therapeutics4/24/2025$25.52$102.00Overweight???%???%ALNYAlnylam Pharmaceuticals4/11/2025$231.02$268.00Equal Weight???%???%KYTXKyverna Therapeutics4/1/2025$1.93$20.00Overweight???%???%CABACabaletta Bio4/1/2025$1.39$22.00Overweight???%???%AARDAardvark Therapeutics3/10/2025$10.13$29.00Overweight???%???%YMABY-mAbs Therapeutics3/5/2025$4.89$7.00Underweight???%???%SLNSilence Therapeutics3/5/2025$4.38$45.00Overweight???%???%KPTIKaryopharm Therapeutics3/3/2025$7.95$54.00Outperform???%???%IOVAIovance Biotherapeutics2/28/2025$5.26$20.00Outperform???%???%ALNYAlnylam Pharmaceuticals2/14/2025$264.89$284.00Equal Weight???%???%THRDThird Harmonic Bio2/12/2025$3.25$5.00Equal Weight???%???%GUTSFractyl Health2/3/2025$1.77$10.00Overweight???%???%AKROAkero Therapeutics1/28/2025$52.07$96.00Overweight???%???%ISEEIVERIC bio7/7/2022$10.44$30.00Overweight???%???%RAREUltragenyx Pharmaceutical7/1/2020$73.66$90.00Outperform???%???%RAREUltragenyx Pharmaceutical4/1/2020$46.91$75.00Buy???%???%ALXNAlexion Pharmaceuticals1/31/2020$101.40$140.00Outperform???%???%FOLDAmicus Therapeutics1/9/2020$9.67$20.00Buy???%???%BMRNBioMarin Pharmaceutical12/13/2019$80.17$120.00Buy???%???%KPTIKaryopharm Therapeutics9/24/2019$148.65$375.00Buy???%???%ALXNAlexion Pharmaceuticals8/30/2019$95.25$165.00Buy???%???%CHRSCoherus Oncology6/19/2019$21.67$28.00Buy???%???%BMRNBioMarin Pharmaceutical4/26/2019$84.63$120.00Buy???%???%FOLDAmicus Therapeutics4/22/2019$12.64$20.00Buy???%???%CHRSCoherus Oncology4/10/2019$14.76$28.00Buy???%???%BMRNBioMarin Pharmaceutical4/2/2019$91.23$120.00Buy???%???%MRSNMersana Therapeutics3/8/2019$113.00$300.00Buy???%???%TSROTesaro12/3/2018$73.50$75.00Hold???%???%MACKMerrimack Pharmaceuticals10/20/2018$4.01$4.00Hold???%???%ALXNAlexion Pharmaceuticals9/24/2018$127.92$165.00Buy???%???%MRSNMersana Therapeutics8/15/2018$316.00$500.00Buy???%???%KPTIKaryopharm Therapeutics8/8/2018$275.70$375.00Buy???%???%TSROTesaro8/3/2018$35.28$40.00Hold???%???%JNCEJounce Therapeutics6/4/2018$11.23$20.00Buy???%???%TSROTesaro4/24/2018$53.06Hold???%???%NLNKNewLink Genetics4/9/2018$4.20$5.00Neutral???%???%KPTIKaryopharm Therapeutics3/15/2018$242.40$330.00Buy???%???%ALXNAlexion Pharmaceuticals3/15/2018$126.83$160.00Buy???%???%PRTOProteon Therapeutics3/15/2018$2.15Outperform???%???%PRTOProteon Therapeutics3/14/2018$2.30$3.00Hold???%???%JNCEJounce Therapeutics3/8/2018$26.08$35.00Buy???%???%FOLDAmicus Therapeutics2/7/2018$16.58$20.00Buy???%???%TSROTesaro8/10/2017$116.18$140.00Neutral???%???%ALXNAlexion Pharmaceuticals6/26/2017$125.09$145.00Neutral???%???%CHRSCoherus Oncology6/13/2017$15.75$37.00Outperform???%???%TSROTesaro6/6/2017$142.48Neutral???%???%FOLDAmicus Therapeutics5/17/2017$7.89$12.00Outperform???%???%PRTKParatek Pharmaceuticals4/4/2017$22.85$40.00Outperform???%???%PRTKParatek Pharmaceuticals3/27/2017$15.85$40.00Positive???%???%PRTOProteon Therapeutics3/16/2017$1.70$3.00Neutral???%???%TSROTesaro3/15/2017$153.65$165.00Positive???%???%CHRSCoherus Oncology2/1/2017$27.90$40.00Outperform???%???%FOLDAmicus Therapeutics1/31/2017$5.50Outperform???%???%FOLDAmicus Therapeutics1/24/2017$5.34$10.00Outperform???%???%MACKMerrimack Pharmaceuticals1/11/2017$34.00$50.00Neutral???%???%ALXNAlexion Pharmaceuticals1/7/2017$143.61$145.00Neutral???%???%ALXNAlexion Pharmaceuticals1/5/2017$127.11Hold???%???%TSROTesaro12/22/2016$136.81$127.00Outperform???%???%PRTKParatek Pharmaceuticals12/13/2016$14.15$40.00Positive???%???%ALXNAlexion Pharmaceuticals12/6/2016$124.93$145.00Neutral???%???%FOLDAmicus Therapeutics11/29/2016$8.39$7.00Hold???%???%BMRNBioMarin Pharmaceutical10/15/2016$85.04$115.00Buy???%???%TSROTesaro10/10/2016$99.26$120.00Outperform???%???%MACKMerrimack Pharmaceuticals8/10/2016$50.80$70.00Neutral???%???%NLNKNewLink Genetics5/10/2016$16.50$23.00Outperform???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access